Clover Corporation Limited (CLV.AX)
ASX · AUD · Consumer Defensive · Packaged Foods
A$1.01 (+2.03%) as of
Key statistics
- Market cap
- 167.83M
- P/E (TTM)
- 16.75
- Forward P/E
- 10.36
- EPS (TTM)
- 0.0600
- Dividend yield
- 2.54%
- 52-week range
- 0.6300 – 1.1650
- Beta
- -0.34
- Revenue (TTM)
- 97.41M
- Profit margin
- 10.74%
- Analyst target
- A$1.32
- Volume
- 285.33k
About Clover Corporation Limited
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Headquarters
- Altona North, VIC, Australia
- Employees
- 81
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.